Larvol Delta - Phase-I-Study-to-Assess-Safety-Tolerability-PK-and-PD-of-AGMB447-in-Healthy-Participants-and-Participants-With-IPF

AGMB-447 - AgomAb Therapeutics

http://clinicaltrials.gov/ct2/show/NCT06181370

Jun 24, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next